AU2001271067A1 - Method of screening compound controlling mek/erk signal transduction and medicinal use of the compound - Google Patents

Method of screening compound controlling mek/erk signal transduction and medicinal use of the compound

Info

Publication number
AU2001271067A1
AU2001271067A1 AU2001271067A AU7106701A AU2001271067A1 AU 2001271067 A1 AU2001271067 A1 AU 2001271067A1 AU 2001271067 A AU2001271067 A AU 2001271067A AU 7106701 A AU7106701 A AU 7106701A AU 2001271067 A1 AU2001271067 A1 AU 2001271067A1
Authority
AU
Australia
Prior art keywords
compound
mek
signal transduction
medicinal use
controlling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271067A
Inventor
Takakazu Mizuno
Jun-Ichi Nezu
Asuka Ose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU2001271067A1 publication Critical patent/AU2001271067A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001271067A 2000-07-19 2001-07-17 Method of screening compound controlling mek/erk signal transduction and medicinal use of the compound Abandoned AU2001271067A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000223892 2000-07-19
JP2000-223892 2000-07-19
PCT/JP2001/006171 WO2002006520A1 (en) 2000-07-19 2001-07-17 Method of screening compound controlling mek/erk signal transduction and medicinal use of the compound

Publications (1)

Publication Number Publication Date
AU2001271067A1 true AU2001271067A1 (en) 2002-01-30

Family

ID=18717928

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271067A Abandoned AU2001271067A1 (en) 2000-07-19 2001-07-17 Method of screening compound controlling mek/erk signal transduction and medicinal use of the compound

Country Status (2)

Country Link
AU (1) AU2001271067A1 (en)
WO (1) WO2002006520A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE392433T1 (en) * 2003-07-17 2008-05-15 Univ Dundee METHOD OF APPLYING AN LKB1/STRAD/MO25 COMPLEX
US7378423B2 (en) 2004-06-11 2008-05-27 Japan Tobacco Inc. Pyrimidine compound and medical use thereof
ES2397825T3 (en) 2004-06-11 2013-03-11 Japan Tobacco, Inc. 5-Amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido [2,3-d] pyrimidine derivatives and related compounds for cancer treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074861A (en) * 1993-04-15 2000-06-13 National Jewish Center For Immunology And Respiratory Medicine MEKK proteins
US6010856A (en) * 1997-09-03 2000-01-04 The Scripps Research Institute Assay systems and methods for measuring P38 map kinase, and modulators thereof
WO1999028459A1 (en) * 1997-11-27 1999-06-10 Chugai Research Institute For Molecular Medicine, Inc. Examination method, examination reagent and remedy for diseases caused by variation in lkb1 gene
AU4951300A (en) * 1999-05-31 2000-12-18 Chugai Research Institute For Molecular Medicine, Inc. Lkb1 gene knockout animals
WO2001010905A1 (en) * 1999-08-06 2001-02-15 Chugai Seiyaku Kabushiki Kaisha Medicinal compositions for inhibiting abnormal proliferation of vascular smooth muscle cells
CA2388343A1 (en) * 1999-11-12 2001-05-17 Mark Steven Marshall Methods for inhibiting neurofibromatosis type 1 (nf1)

Also Published As

Publication number Publication date
WO2002006520A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
AU4856500A (en) Acoustic transducer and method of making the same
AU2002364528A1 (en) Bio-implant and method of making the same
AU6886598A (en) Hosel construction and method of making the same
AU3146301A (en) Adjustable staircase and method of assembling the same
AU2001275474A1 (en) Materials and methods for the control of nematodes
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU5326299A (en) Inflatable cannula and method of using same
AU2001245928A1 (en) Electrolyzer and method of using the same
AU2001267079A1 (en) Integrated electronic-optoelectronic devices and method of making the same
AU2001270943A1 (en) Surgical instrument and method of using the same
AU6117700A (en) Microfabricated devices and method of manufacturing the same
AU2001234473A1 (en) Stabilized silica and methods of making and using the same
AU7167298A (en) Inhibitors of the jnk signal transduction pathway and methods of use
AU2781199A (en) Pulsed-energy controllers and methods of operation thereof
AU6099100A (en) Ultra-rugged i.c. sensor and method of making the same
AU2001257075A1 (en) Screen and method of making the same
AU2002314466A1 (en) Withasol and methods of use
AU2000273206A1 (en) Photocatalyst-bearing material and method of producing the same
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001296581A1 (en) Micromachined component and method of manufacture
AU2002230606A1 (en) Glazing unit and method of making the same
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2002228801A1 (en) Post-crepe stabilized material and method of producing the same
AU2001264910A1 (en) Plasticizable mixture and method of using
AU2003297612A1 (en) 2-substituted-3-propenamide derivatives and methods of using the same